spacer
The Healthcare Sales & Marketing Network celebrates 20 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare News Roundup: Mergers & Acquisitions

 HSMN NewsFeed - 12 Oct 2018
Varian Expands Cancer Care Portfolio with Noona Healthcare Acquisition
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 12 Oct 2018
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Sep 2018
LYNCH Biologics Closes on Transaction to Purchase GEM 21S(R) Growth Factor Enhanced Matrix for Dental Bone Regeneration
Devices Biopharmaceuticals Dental Acquisitions
 HSMN NewsFeed - 25 Sep 2018
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2018
Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 21 Sep 2018
Almirall acquires Allergan U.S. medical dermatology portfolio*
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 14 Sep 2018
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 7 Sep 2018
BD Statement on Divestiture of Advanced Bioprocessing Business
Devices Diagnostics Acquisitions
 HSMN NewsFeed - 7 Sep 2018
Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD
Devices Diagnostics Acquisitions
 HSMN NewsFeed - 5 Sep 2018
Syneron Candela Announces Acquisition Of Ellipse
Devices Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 24 Aug 2018
Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Acquires Momelotinib, an Investigational Janus Kinase (JAK) 1/2 and Activin Receptor Type 1 (ACVR1) Inhibitor for Myelofibrosis, from Gilead Sciences
Biopharmaceuticals Oncology Acquisitions
Older Acquisitions stories   Return to NewsFeed  
RepFinder 2 - Find Great Medical Independent Sales Reps without recruiter fees.
RepFinder 2 - available on the Apple App Store for iPhone and iPad.